WHEN
Wednesday, March 16, 2022
2:00pm
Since Bay Area Tigers are so active in biotech and entrepreneurship, the Princeton Club of Hilton Head has extended an invitation to their upcoming author event with Lisa Drakeman *88 and Don Drakeman *88. This event is open to Princeton alumni only and is not open to the public. We hope to see you there!
From Breakthrough to Blockbuster: The Business of Biotechnology, Oxford University Press, 2022.
A talk by authors Lisa Drakeman *88, S*88, P’02, h’35 and Don Drakeman *88, S*88, P’02.
Join the Princeton Club of Hilton Head for a conversation with authors and biotech entrepreneurs Dr. Lisa Drakeman and Dr. Don Drakeman to learn how new medicines get made, why the process is so complex (and expensive!), and what it takes to succeed in a start up.
Learn about entrepreneurship and find out if you are an entrepreneur!
Wednesday, March 16, 5:00 PM EDT
Click here to register for the Zoom link
RSVP by Friday, March 11
The account of how a vast collection of inexperienced, underfunded, and unprofitable small companies have created more life-changing new medicines than the largest global pharmaceutical firms is a David-and-Goliath story well worth reading.
Buying the book is optional.
The following brief excerpts are recommended in advance of the talk:
- How GSK Missed a $32 Billion Opportunity with the COVID-19 Vaccine (scroll down the home page for the excerpt)
- Are You an Entrepreneur?
Visit https://www.thebusinessofbiotechnology.com to read additional excerpts and learn more about the book.
About the Authors
Lisa Drakeman, PhD, was the founding CEO of one of Europe’s most successful biotechnology companies. Under her leadership, the company set numerous financing records, including a record setting IPO, and inaugurated research programs leading to new FDA-approved medicines. She regularly lectures on entrepreneurship at universities in the US and Europe. She received a PhD from Princeton, where she sits on the Executive Committee of the Alumni Council, and serves as President of the Princeton Club of Hilton Head, Scott Foster Chapter.
Donald Drakeman, PhD, was the founding CEO of the US biotech company that pioneered the development of the cancer treatments recognized in the Nobel Prize for Medicine 2018. He is a Fellow in Health Management at Cambridge University, and a Venture Partner at Advent Life Sciences. He received a PhD from Princeton, and serves as the Treasurer of the Princeton Club of Hilton Head, Scott Foster Chapter.